FDA Inspection
Biocon Biologics LimitedBiocon Biologics Limited – FDA Inspection, Feb 15, 2019
Record Details
This FDA Inspection record concerns Biocon Biologics Limited, with an inspection on February 15, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Diane L. Raccasi (Issuing Officer)
- Michael Shanks (Issuing Officer)
View Company Profile
ID · 01806310-a16e-45b3-914e-99cd14c2f9da
Inspection Facts
- Inspection number
- 1080031
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Biocon Biologics Limited
12| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2019 | Not classified | Office of Inspections and Investigations | |
| August 30, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Biocon Biologics Limited
- FDA Inspection 1245708 - 2024-07-26
- FDA Inspection 1114628 - 2019-09-19
- FDA Inspection 1100840 - 2019-08-30
- FDA Inspection 1050980 - 2018-05-01
- FDA Inspection 1016114 - 2017-06-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.